Evidence map›Paper›PMID 41602112›Full record

ArticleFrontiers in cellular and infection microbiology2025

Risk factors, and outcomes of patients with carbapenem-resistant

Haifang Kong, Yong Liu, Yaqing Wang, Ling Yang, Qianqian Chen, Yanchun Li, Zuoliang Dong, Zhidong Hu, Yamin Chai, Xiuyu Wang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. JAC-antimicrobial resistance · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Haifang Kong *Department of Laboratory Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Yong Liu *Department of Neurosurgery, Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China.
Yaqing WangQingdao Eighth People's Hospital, Shandong, China.
Ling YangDepartment of Laboratory Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Qianqian ChenDepartment of Laboratory Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Yanchun LiDepartment of Laboratory Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Zuoliang DongDepartment of Laboratory Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Zhidong HuDepartment of Laboratory Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Yamin ChaiDepartment of Laboratory Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Xiuyu WangDepartment of Neurosurgery, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Hua YanDepartment of Neurosurgery, Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant

Indexed as

Anti-Bacterial AgentsBacteremiaCarbapenem-Resistant EnterobacteriaceaeCarbapenemsEnterobacteriaceae InfectionsAgedAged, 80 and overCase-Control StudiesFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsThird Generation CephalosporinsTreatment OutcomeAnti-Bacterial AgentsCarbapenemsThird Generation Cephalosporinsbloodstream infectioncarbapenem-resistant Enterobacteralescase-case-control studyoutcomesrisk factor

Identifiers

PMID41602112
PMCPMC12832737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.